Cargando…
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
Progress has been made in COVID-19 vaccine development, with encouraging safety and efficacy data. The purpose of this study was to investigate the immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases (AIIRD). Patients with AIIRD (n = 101) were i...
Autores principales: | Zheng, Yi-Qing, Li, He-Jun, Chen, Ling, Lin, Shun-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606114/ https://www.ncbi.nlm.nih.gov/pubmed/36289319 http://dx.doi.org/10.1038/s41598-022-22839-0 |
Ejemplares similares
-
Autoimmune inflammatory rheumatic diseases post-COVID‐19 vaccination
por: Safary, Azam, et al.
Publicado: (2022) -
The COVID‐19 vaccine: Attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases
por: Chen, Jiali, et al.
Publicado: (2022) -
Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016) -
Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines
por: Fan, Yong, et al.
Publicado: (2022) -
Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study
por: Zeng, Huiqiong, et al.
Publicado: (2022)